Rockefeller Capital Management
BCYC

Rockefeller Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

Rockefeller Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23 Hold
5
– – ﹤0.01% 4661
2025
Q4 		$35 Hold
5
– – ﹤0.01% 4649
2025
Q3 		$39 Buy
+5
New +$38 ﹤0.01% 4401
2023
Q1 		– Sell
-213
Closed -$6K – 2156
2022
Q4 		$6K Hold
213
– – ﹤0.01% 3253
2022
Q3 		$4K Hold
213
– – ﹤0.01% 3381
2022
Q2 		$3K Buy
213
+48
+29% +$1.01K ﹤0.01% 3620
2022
Q1 		$7K Hold
165
– – ﹤0.01% 3198
2021
Q4 		$10K Sell
165
-181
-52% -$9.99K ﹤0.01% 2965
2021
Q3 		$14K Buy
+346
New +$12.1K ﹤0.01% 2726

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rockefeller Capital Management's BCYC Position: Q1 2026 in Review

Rockefeller Capital Management held its Bicycle Therapeutics (BCYC) position steady in Q1 2026 at 5 shares worth $23. The position accounts for ﹤0.01% of the portfolio, ranked #4661.

Rockefeller Capital Management first reported a position in BCYC in Q3 2021 and has held it in 9 quarters since. The position peaked at $14K in Q3 2021. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Rockefeller Capital Management held 5 shares of Bicycle Therapeutics worth $23 as of Q1 2026.
  • Rockefeller Capital Management left its Bicycle Therapeutics share count unchanged in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4661 holding.
  • Rockefeller Capital Management first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Bicycle Therapeutics position peaked at $14K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.